A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU [fluorouracil] in Patients With Highly Advanced Hepatocellular Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 31 May 2016
At a glance
- Drugs Interferon alpha (Primary) ; Cisplatin; Fluorouracil
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 01 Feb 2012 Results published in Hepatology Research.
- 21 Jul 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 21 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.